
Opinion|Videos|June 28, 2024
Latest Trends and Innovations in Multiple Myeloma Management at EHA 2024
Joseph Mikhael, MD, discusses the latest trends and innovations regarding multiple myeloma management.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- What are the latest trends and innovations you have observed in the treatment and management of multiple myeloma leading up to the European Hematology Association Hybrid Congress?
- Let’s begin first with newly diagnosed multiple myeloma (NDMM). How has the paradigm of NDMM management shifted in recent history?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5














































